Session XVII: Adjuvant and Neoadjuvant Treatment of Colon Cancer

Chair(s)

• 

  John Marshall, MD

  Lombardi Comprehensive Cancer Center, Georgetown University
  Washington, United States
• 

  Eric Van Cutsem, MD, PhD

  University Hospitals Leuven / KU Leuven
  Leuven, Belgium

Presentations:

• 15:40 – 15:50 CEST

  Debate: Are We Ready to Integrate ctDNA in Treatment Selection - YES
  

  Debate Speaker: Jeanne Tie, MBChB FRACP MD – Peter MacCallum Cancer Centre
• 15:45 – 15:55 CEST

  Debate: Neoadjuvant Therapy in Locally Advanced Colon Cancer - YES
  

  Debate Speaker: Jenny Seligmann, MBChB, PhD – University of Leeds
• 15:50 – 16:00 CEST

  Debate: Are We Ready to Integrate ctDNA in Treatment Selection - NO
  

  Debate Speaker: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital
• 15:55 – 16:05 CEST

  Debate: Neoadjuvant Therapy in Locally Advanced Colon Cancer - NO
  

  Debate Speaker: Thierry André, MD – Hopital Saint Antoine
• 16:00 – 16:10 CEST

  Debate: Are We Ready to Integrate ctDNA in Treatment Selection - DISCUSSION
  

  Panelist: Jeanne Tie, MBChB FRACP MD – Peter MacCallum Cancer Centre

  Panelist: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital
• 16:05 – 16:15 CEST

  Debate: Neoadjuvant Therapy in Locally Advanced Colon Cancer - DISCUSSION
  

  Panelist: Jenny Seligmann, MBChB, PhD – University of Leeds

  Panelist: Thierry André, MD – Hopital Saint Antoine
• 16:15 – 16:40 CEST

  Keynote Lecture: Single Cell Analysis and Transcriptomics
  

  Keynote Speaker: Sabine Tejpar, MD PhD – University Hospitals Leuven / KU Leuven